These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 7620699

  • 1. Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type.
    Davenport AP, O'Reilly G, Kuc RE.
    Br J Pharmacol; 1995 Mar; 114(6):1110-6. PubMed ID: 7620699
    [Abstract] [Full Text] [Related]

  • 2. Endothelin receptors in human coronary artery and aorta.
    Bacon CR, Davenport AP.
    Br J Pharmacol; 1996 Mar; 117(5):986-92. PubMed ID: 8851522
    [Abstract] [Full Text] [Related]

  • 3. Human endothelin receptors characterized using reverse transcriptase-polymerase chain reaction, in situ hybridization, and subtype-selective ligands BQ123 and BQ3020: evidence for expression of ETB receptors in human vascular smooth muscle.
    Davenport AP, O'Reilly G, Molenaar P, Maguire JJ, Kuc RE, Sharkey A, Bacon CR, Ferro A.
    J Cardiovasc Pharmacol; 1993 Mar; 22 Suppl 8():S22-5. PubMed ID: 7509950
    [Abstract] [Full Text] [Related]

  • 4. [125I]-PD151242: a selective ligand for endothelin ETA receptors in human kidney which localizes to renal vasculature.
    Davenport AP, Kuc RE, Hoskins SL, Karet FE, Fitzgerald F.
    Br J Pharmacol; 1994 Dec; 113(4):1303-10. PubMed ID: 7534185
    [Abstract] [Full Text] [Related]

  • 5. Endothelin ETA receptor expression in human cerebrovascular smooth muscle cells.
    Yu JC, Pickard JD, Davenport AP.
    Br J Pharmacol; 1995 Nov; 116(5):2441-6. PubMed ID: 8581282
    [Abstract] [Full Text] [Related]

  • 6. Characterization of [125I]-PD164333, an ETA selective non-peptide radiolabelled antagonist, in normal and diseased human tissues.
    Davenport AP, Kuc RE, Ashby MJ, Patt WC, Doherty AM.
    Br J Pharmacol; 1998 Jan; 123(2):223-30. PubMed ID: 9489609
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart.
    Peter MG, Davenport AP.
    Br J Pharmacol; 1996 Feb; 117(3):455-462. PubMed ID: 8821534
    [Abstract] [Full Text] [Related]

  • 8. ETA and ETB endothelin receptors in human myometrium characterized by the subtype selective ligands BQ123, BQ3020, FR139317 and PD151242.
    Bacon CR, Morrison JJ, O'Reilly G, Cameron IT, Davenport AP.
    J Endocrinol; 1995 Jan; 144(1):127-34. PubMed ID: 7891013
    [Abstract] [Full Text] [Related]

  • 9. [125I]-PD151242: a selective radioligand for human ETA receptors.
    Davenport AP, Kuc RE, Fitzgerald F, Maguire JJ, Berryman K, Doherty AM.
    Br J Pharmacol; 1994 Jan; 111(1):4-6. PubMed ID: 8012722
    [Abstract] [Full Text] [Related]

  • 10. Characterization of endothelin receptors in human brain cortex, gliomas, and meningiomas.
    Harland SP, Kuc RE, Pickard JD, Davenport AP.
    J Cardiovasc Pharmacol; 1995 Jan; 26 Suppl 3():S408-11. PubMed ID: 8587429
    [Abstract] [Full Text] [Related]

  • 11. ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro.
    Maguire JJ, Davenport AP.
    Br J Pharmacol; 1995 May; 115(1):191-7. PubMed ID: 7647976
    [Abstract] [Full Text] [Related]

  • 12. Endothelin-1 binding to endothelin receptors in the rat anterior pituitary gland: possible formation of an ETA-ETB receptor heterodimer.
    Harada N, Himeno A, Shigematsu K, Sumikawa K, Niwa M.
    Cell Mol Neurobiol; 2002 Apr; 22(2):207-26. PubMed ID: 12363203
    [Abstract] [Full Text] [Related]

  • 13. Vasoconstrictor endothelin receptors characterized in human renal artery and vein in vitro.
    Maguire JJ, Kuc RE, O'Reilly G, Davenport AP.
    Br J Pharmacol; 1994 Sep; 113(1):49-54. PubMed ID: 7812631
    [Abstract] [Full Text] [Related]

  • 14. Selectivity of [125I]-PD151242 for human, rat and porcine endothelin ETA receptors in the heart.
    Peter MG, Davenport AP.
    Br J Pharmacol; 1995 Jan; 114(2):297-302. PubMed ID: 7881728
    [Abstract] [Full Text] [Related]

  • 15. Characterization of [125I]-endothelin-1 and [125I]-BQ3020 binding to rat cerebellar endothelin receptors.
    Widdowson PS, Kirk CN.
    Br J Pharmacol; 1996 Aug; 118(8):2126-30. PubMed ID: 8864551
    [Abstract] [Full Text] [Related]

  • 16. Characterization of peptide and nonpeptide antagonists in human kidney.
    Kuc RE, Karet FE, Davenport AP.
    J Cardiovasc Pharmacol; 1995 Aug; 26 Suppl 3():S373-5. PubMed ID: 8587419
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the binding of endothelin ETB selective ligands in human and rat heart.
    Russell FD, Davenport AP.
    Br J Pharmacol; 1996 Oct; 119(4):631-6. PubMed ID: 8904635
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological characterization of the rat cerebellar endothelin B (ETB) receptor using the novel agonist radioligand [125I]BQ3020.
    Jarvis MF, Assal AA, Gessner G.
    Brain Res; 1994 Nov 28; 665(1):33-8. PubMed ID: 7882015
    [Abstract] [Full Text] [Related]

  • 19. Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney.
    Karet FE, Kuc RE, Davenport AP.
    Kidney Int; 1993 Jul 28; 44(1):36-42. PubMed ID: 8355464
    [Abstract] [Full Text] [Related]

  • 20. ETA receptors predominate in the human vasculature and mediate constriction.
    Davenport AP, Kuc RE, Maguire JJ, Harland SP.
    J Cardiovasc Pharmacol; 1995 Jul 28; 26 Suppl 3():S265-7. PubMed ID: 8587384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.